NRSN NeuroSense Therapeutics Ltd.
Fundamentals / CIK 0001875091 / USDNeuroSense Therapeutics Ltd. reported $1.03M in total assets and a net loss of $11.12M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NRSN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$11.09M Operating profit
-
Net Income FY 2025-$11.12M GAAP bottom line
-
Diluted EPS FY 2025-$0.44 Split-adjusted
-
Free Cash Flow FY 2025-$7.68M Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2025$166K Total debt: $170K
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Research & Development | $6.23M | $5.70M | $7.27M | $5.59M | -- | -- | -- |
| Operating Income | -$11.09M | -$9.90M | -$12.05M | -$10.55M | -$5.59M | -$2.89M | -$1.24M |
| EBITDA | -$11.07M | -$9.88M | -$12.03M | -$10.54M | -$5.58M | -$2.88M | -- |
| Interest Income | -- | -- | $4.23M | $1.26M | $2.73M | $61K | $18K |
| Interest Expense | -- | -- | $2.21M | $45K | $1.19M | $1.0K | $5.0K |
| Net Income | -$11.12M | -$10.21M | -$10.11M | -$10.49M | -$4.04M | -$2.83M | -$1.22M |
| Basic EPS | -$0.44 | -$0.54 | -$0.74 | -$0.91 | -$0.65 | -$0.51 | -$0.26 |
| Diluted EPS | -$0.44 | -$0.54 | -$0.74 | -$0.91 | -$0.65 | -$0.51 | -- |
| Basic Shares Outstanding | 25.5M | 18.6M | 13.6M | 11.5M | -- | -- | -- |
| Diluted Shares Outstanding | 25.5M | 18.6M | 13.6M | 11.5M | -- | -- | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $166K | $3.38M | $2.64M | $3.54M | $11.06M | $699K |
| Cash & Short-Term Investments | $166K | $3.38M | $2.64M | $3.54M | $11.06M | $699K |
| Accounts Receivable, Net | -- | -- | $236K | $255K | $310K | $30K |
| Total Current Assets | $778K | $4.40M | $2.92M | $7.38M | $11.41M | $766K |
| Property, Plant & Equipment, Net | $58K | $66K | $85K | $77K | $19K | $13K |
| Total Non-Current Assets | $250K | $173K | $269K | $329K | $19K | $13K |
| Total Assets | $1.03M | $4.58M | $3.19M | $7.71M | $11.43M | $779K |
| Accounts Payable | $799K | $1.16M | $1.46M | $498K | $39K | $55K |
| Other Current Liabilities | $1.72M | $832K | $2.00M | -- | -- | -- |
| Total Current Liabilities | $2.52M | $1.99M | $3.46M | $1.73M | $597K | $120K |
| Total Non-Current Liabilities | $72K | $0 | $1.49M | $365K | $1.83M | $0 |
| Total Liabilities | $2.59M | $1.99M | $4.94M | $2.09M | $2.42M | $120K |
| Total Debt (incl. Leases) | $170K | $73K | $69K | $294K | -- | -- |
| Retained Earnings | -$47.78M | -$36.66M | -$26.12M | -$20.79M | -$8.45M | -$4.41M |
| Total Stockholders' Equity | -$1.56M | $2.58M | -$1.76M | $5.84M | $10.83M | $659K |
| Total Equity | -$1.56M | $2.58M | -$1.76M | $5.84M | $10.83M | $659K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $166K | $3.38M | $2.64M | $3.54M | $11.06M | $699K |
| Cash & Short-Term Investments | $166K | $3.38M | $2.64M | $3.54M | $11.06M | $699K |
| Accounts Receivable, Net | -- | -- | $236K | $255K | $310K | $30K |
| Total Current Assets | $778K | $4.40M | $2.92M | $7.38M | $11.41M | $766K |
| Property, Plant & Equipment, Net | $58K | $66K | $85K | $77K | $19K | $13K |
| Total Non-Current Assets | $250K | $173K | $269K | $329K | $19K | $13K |
| Total Assets | $1.03M | $4.58M | $3.19M | $7.71M | $11.43M | $779K |
| Accounts Payable | $799K | $1.16M | $1.46M | $498K | $39K | $55K |
| Other Current Liabilities | $1.72M | $832K | $2.00M | -- | -- | -- |
| Total Current Liabilities | $2.52M | $1.99M | $3.46M | $1.73M | $597K | $120K |
| Total Non-Current Liabilities | $72K | $0 | $1.49M | $365K | $1.83M | $0 |
| Total Liabilities | $2.59M | $1.99M | $4.94M | $2.09M | $2.42M | $120K |
| Total Debt (incl. Leases) | $170K | $73K | $69K | $294K | -- | -- |
| Retained Earnings | -$47.78M | -$36.66M | -$26.12M | -$20.79M | -$8.45M | -$4.41M |
| Total Stockholders' Equity | -$1.56M | $2.58M | -$1.76M | $5.84M | $10.83M | $659K |
| Total Equity | -$1.56M | $2.58M | -$1.76M | $5.84M | $10.83M | $659K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$11.12M | -$10.21M | -$10.11M | -$10.49M | -$4.04M | -$2.83M | -$1.22M |
| Depreciation & Amortization | $16K | $22K | $21K | $12K | $3.0K | $3.0K | -- |
| Stock-Based Compensation | $2.14M | $557K | $1.54M | $1.73M | $4.16M | $2.06M | $611K |
| Change in Payables | -$361K | -$299K | $961K | $459K | -$16K | $32K | $23K |
| Operating Cash Flow | -$7.67M | -$10.13M | -$8.35M | -$7.62M | -$1.54M | -$695K | -$582K |
| Capital Expenditure | -$8.0K | -$3.0K | -$29K | -$70K | -$17K | -$9.0K | -$7.0K |
| Free Cash Flow | -$7.68M | -$10.14M | -$8.38M | -$7.69M | -$1.56M | -$704K | -$589K |
| Investing Cash Flow | -$8.0K | $1.0K | $3.47M | -$3.59M | -$17K | -$9.0K | -$26K |
| Common Stock Issued | $7.0K | -- | $3.97M | -- | $9.86M | $508K | $1.42M |
| Dividends Paid | -- | -- | -$310K | -$310K | -$29K | -$28K | -$27K |
| Financing Cash Flow | $4.43M | $10.91M | $3.98M | $3.77M | $11.90M | $508K | $1.42M |
| Net Change in Cash | -- | -- | -$903K | -$7.52M | $10.36M | -$196K | $809K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -395.3% | -- | -179.5% | -37.3% | -429.1% | -- |
| Return on Assets (ROA) | -1082.2% | -223.2% | -317.3% | -136.1% | -35.4% | -363.0% | -- |
| Current Ratio | 0.31x | 2.21x | 0.84x | 4.28x | 19.12x | 6.38x | -- |
| Quick Ratio | 0.07x | 1.70x | 0.83x | 2.20x | 19.05x | 6.08x | -- |
| Debt to Equity | -- | 0.03x | -- | 0.05x | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.